We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEF icon
876
Sprott Physical Gold and Silver Trust
CEF
$8.06B
$9.37M 0.01%
708,155
-12,006
-2% -$150K
OC icon
877
Owens Corning
OC
$12.4B
$9.35M 0.01%
160,596
+9,976
+7% +$509K
K
878
DELISTED
Kellanova
K
$9.35M 0.01%
185,808
+35,575
+24% +$1.89M
APTV icon
879
Aptiv
APTV
$10.3B
$9.33M 0.01%
115,426
-15,162
-12% -$1.2M
IXN icon
880
iShares Global Tech ETF
IXN
$9.26B
$9.31M 0.01%
311,238
-54,240
-15% -$1.58M
VST icon
881
Vistra
VST
$47.4B
$9.31M 0.01%
411,151
+9,768
+2% +$245K
WPC icon
882
W.P. Carey
WPC
$16.4B
$9.3M 0.01%
116,950
-7,285
-6% -$577K
HOLX
883
DELISTED
Hologic
HOLX
$9.29M 0.01%
193,390
+62,495
+48% +$2.89M
HXL icon
884
Hexcel
HXL
$7.82B
$9.26M 0.01%
114,452
-7,897
-6% -$574K
DBEF icon
885
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.39B
$9.25M 0.01%
292,713
+95,368
+48% +$3.03M
LILAK icon
886
Liberty Latin America Class C
LILAK
$1.64B
$9.24M 0.01%
627,979
-284
-0% -$4.64K
HEFA icon
887
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.76B
$9.24M 0.01%
309,727
+30,814
+11% +$905K
TPL icon
888
Texas Pacific Land
TPL
$23.5B
$9.23M 0.01%
105,417
+7,893
+8% +$708K
TTD icon
889
Trade Desk
TTD
$6.49B
$9.21M 0.01%
404,460
+224,880
+125% +$4.83M
QEMM icon
890
State Street SPDR MSCI Emerging Markets StrategicFactors ETF
QEMM
$60.2M
$9.15M 0.01%
154,217
+17,199
+13% +$1.01M
KRE icon
891
State Street SPDR S&P Regional Banking ETF
KRE
$4.57B
$9.14M 0.01%
171,052
+59,146
+53% +$3.16M
ROKU icon
892
Roku
ROKU
$22.7B
$9.11M 0.01%
100,616
-4,966
-5% -$399K
FG
893
DELISTED
FGL Holdings Ordinary Shares
FG
$9.06M 0.01%
1,078,974
+1,775
+0.2% +$14.9K
RFDA icon
894
ALPS Dynamic US Dividend Advantage ETF
RFDA
$89.4M
$9.06M 0.01%
280,819
-3,904
-1% -$125K
NOMD icon
895
Nomad Foods
NOMD
$1.68B
$9.05M 0.01%
423,922
+9,593
+2% +$201K
ARCC icon
896
Ares Capital
ARCC
$14.4B
$9.05M 0.01%
504,677
-10,643
-2% -$188K
SMDV icon
897
ProShares Russell 2000 Dividend Growers ETF
SMDV
$710M
$9.05M 0.01%
152,747
+45,461
+42% +$2.68M
HEI icon
898
HEICO Corp
HEI
$51.4B
$9.05M 0.01%
67,611
+364
+0.5% +$40.5K
CUB
899
DELISTED
Cubic Corporation
CUB
$9.03M 0.01%
140,035
+53,324
+61% +$3.13M
KMX icon
900
CarMax
KMX
$8.26B
$9.02M 0.01%
103,889
-4,644
-4% -$363K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.